Synthesis and in vitro antiplasmodial activityof quinoline-ferrocene esters

Abstract New 4-aminoquinoline-derived esterscontaining the redox-active ferrocenegroup brought in by either ferrocenyfor-mic or 4-ferrocenylbutanoic acids weresynthesized and tested in vitro for theirantiplasmodial activity. The results re-vealed that only esters derived from fer-rocenylformic acid were active againstboth chloroquine (CQ)-resistant Dd2 andCQ-sensitive D10 strains of Plasmodium falciparum. However, none of theseshowed higher actvity than CQ against the sensitive strain. Ester 16, which pos-sesses a butyl branch in the structure,was the most active of all. With an IC50 of0.13 mM on the resistant strain, this esterpossessed 2.5-fold higher activity than CQ(IC50 = 0.34 mM). All tested esters showedgood selectivity towards P. falciparum with indexes higher than 60.

[1]  C. Lategan,et al.  Synthesis, cytotoxicity and antimalarial activity of ferrocenyl amides of 4-aminoquinolines , 2010, Arzneimittelforschung.

[2]  H. Hou,et al.  Ferrocenyl Functional Coordination Polymers Based on Mono-, Bi-, and Heterotrinuclear Organometallic Building Blocks: Syntheses, Structures, and Properties , 2009 .

[3]  C. Biot,et al.  Investigation of the redox behavior of ferroquine, a new antimalarial. , 2008, Molecular pharmaceutics.

[4]  F. Bigucci,et al.  Transport of fluoroalkyl dihydroartemisinin derivatives across rat intestinal tissue , 2008, The Journal of pharmacy and pharmacology.

[5]  M. M. Abd-Elzaher,et al.  Medicinal Chemistry of Ferrocene , 2007 .

[6]  S. Burgess,et al.  A chloroquine-like molecule designed to reverse resistance in Plasmodium falciparum. , 2006, Journal of medicinal chemistry.

[7]  C. Biot,et al.  Probing the role of the covalent linkage of ferrocene into a chloroquine template. , 2006, Journal of medicinal chemistry.

[8]  E. De Clercq,et al.  Design and synthesis of hydroxyferroquine derivatives with antimalarial and antiviral activities. , 2006, Journal of medicinal chemistry.

[9]  D. Osella,et al.  FACS analysis of oxidative stress induced on tumour cells by SERMs , 2005 .

[10]  N. Metzler‐Nolte,et al.  Bioorganometallic chemistry of ferrocene. , 2004, Chemical reviews.

[11]  Nicholas J White,et al.  Antimalarial drug resistance. , 2004, The Journal of clinical investigation.

[12]  B. Greenwood,et al.  Mass administrations of antimalarial drugs. , 2003, Trends in parasitology.

[13]  H. Lander,et al.  Ferrocene‐induced lymphocyte activation and antitumor activity is mediated by redox‐sensitive signaling , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[14]  J. Swarts,et al.  Structure and electrochemistry of various diruthenium(II, III) tetrametallocenecarboxylates , 2002 .

[15]  I. Viano,et al.  Water stability and cytotoxic activity relationship of a series of ferrocenium derivatives. ESR insights on the radical production during the degradation process. , 2002, Journal of medicinal chemistry.

[16]  G. Leclercq,et al.  Studies on organometallic selective estrogen receptor modulators. (SERMs) Dual activity in the hydroxy-ferrocifen series , 2001 .

[17]  D. Dive,et al.  Novel ferrocenic artemisinin derivatives: synthesis, in vitro antimalarial activity and affinity of binding with ferroprotoporphyrin IX. , 2000, Bioorganic & medicinal chemistry.

[18]  C. Biot,et al.  Synthetic Ferrocenic Mefloquine and Quinine Analogues as Potential Antimalarial Agents. , 2000 .

[19]  J. Urbina,et al.  Toward a novel metal-based chemotherapy against tropical diseases. , 2000 .

[20]  C. Biot,et al.  Synthesis and antimalarial activity in vitro of potential metabolites of ferrochloroquine and related compounds. , 1999, Bioorganic & medicinal chemistry.

[21]  K. Marsh.  Malaria disaster in Africa , 1998, The Lancet.

[22]  C. Biot,et al.  Synthesis and antimalarial activity in vitro and in vivo of a new ferrocene-chloroquine analogue. , 1997, Journal of medicinal chemistry.

[23]  H. Tamura,et al.  DNA Cleaving Activity and Cytotoxic Activity of Ferricenium Cations , 1997 .

[24]  R. Sánchez-Delgado,et al.  Toward a novel metal-based chemotherapy against tropical diseases. 3. Synthesis and antimalarial activity in vitro and in vivo of the new gold-chloroquine complex [Au(PPh3)(CQ)]PF6. , 1997, Journal of medicinal chemistry.

[25]  D. Schiffrin,et al.  Chemiluminescence of luminol catalyzed by electrochemically oxidized ferrocenes. , 1996, Analytical chemistry.

[26]  J. Urbina,et al.  Toward a novel metal-based chemotherapy against tropical diseases. 2. Synthesis and antimalarial activity in vitro and in vivo of new ruthenium- and rhodium-chloroquine complexes. , 1996, Journal of medicinal chemistry.

[27]  J. Urbina,et al.  Toward a novel metal-based chemotherapy against tropical diseases. 1. Enhancement of the efficacy of clotrimazole against Trypanosoma cruzi by complexation to ruthenium in RuCl2(clotrimazole)2. , 1993, Journal of medicinal chemistry.

[28]  R. Piper,et al.  Parasite lactate dehydrogenase as an assay for Plasmodium falciparum drug sensitivity. , 1993, The American journal of tropical medicine and hygiene.

[29]  A. Gajanana,et al.  Synthesis of metal complexes of antimalarial drugs and in vitro evaluation of their activity against plasmodium falciparum , 1987 .

[30]  N. Farrell,et al.  Trypanocidal and antitumour activity of platinum-metal and platinum-metal-drug dual-function complexes. , 1984, Biochemical pharmacology.

[31]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[32]  H. Köpf,et al.  Titanocene dichloride--the first metallocene with cancerostatic activity. , 1979, Angewandte Chemie.

[33]  W. Trager,et al.  Human malaria parasites in continuous culture. , 1976, Science.

[34]  P. Roepe,et al.  Synthesis and antimalarial activity of new 4-amino-7-chloroquinolyl amides, sulfonamides, ureas and thioureas. , 2009, Bioorganic & medicinal chemistry.

[35]  H. Köpf,et al.  Ferricenium complexes: A new type of water-soluble antitumor agent , 2004, Journal of Cancer Research and Clinical Oncology.